News|Articles|November 16, 2026

5 Things to Know About Shorter Radiation for Prostate Cancer

Listen
0:00 / 0:00

Key Takeaways

  • Moderate hypofractionation is strongly preferred over conventional fractionation for localized prostate cancer across risk strata, supported by >7,000 randomized-trial patients with comparable control, toxicity, and QoL outcomes.
  • SBRT/ultrahypofractionation in five fractions is recommended for intermediate-risk and treated low-risk disease, while high-risk and very-high-risk use is conditionally supported pending more mature evidence.
SHOW MORE

An updated ASTRO guideline released Oct. 27, 2026, says most men getting radiation for prostate cancer that has not spread can safely finish treatment in weeks instead of months, and many can finish in five sessions. Here is what that means for patients.

For decades, men treated with radiation for prostate cancer often had to come in five days a week for about two months. That is changing. On Oct. 27, 2026, the American Society for Radiation Oncology (ASTRO) released an updated guideline saying that shorter courses of radiation should be standard for most men whose prostate cancer has not spread beyond the prostate. The guideline replaces ASTRO's 2018 recommendations and was developed with the American Society of Clinical Oncology (ASCO) and the European Society for Radiotherapy and Oncology.

Here are five things patients and families should know.

1. Prostate Cancer at Any Risk Level: About a Month of Radiation Is Now the Standard

The guideline strongly recommends "moderate hypofractionation" over traditional radiation for men in every risk group. Hypofractionation means giving a slightly larger dose of radiation at each visit so fewer visits are needed. In practice, that typically means 20 treatments over about four weeks, or 28 treatments over five to six weeks.

This recommendation applies regardless of a man's age, other health conditions, anatomy or how well he urinates before treatment. ASTRO said randomized trials involving more than 7,000 patients show that this approach controls cancer as well as longer courses, with similar side effects and long-term quality of life.

2. Prostate Cancer Treated in Five Sessions Is a Standard Option for Many

An even shorter approach, called stereotactic body radiation therapy (SBRT) or ultrahypofractionation, delivers higher, very precise doses in just five treatments, usually over one to two weeks. The guideline recommends SBRT for men with intermediate-risk disease and for men with low-risk disease who choose treatment instead of active surveillance (careful monitoring without immediate treatment).

For high-risk and very-high-risk cancers, SBRT is "conditionally" recommended, meaning experts think it is a reasonable choice for many men but the evidence is less complete. Dr. Scott C. Morgan, the guideline task force chair and a radiation oncologist at The Ottawa Hospital, said in ASTRO's announcement that SBRT is now a standard option for many patients rather than an alternative.

3. Prostate Cancer With Urinary Problems: The Longer of the Short Options

Radiation to the prostate can irritate the bladder and urethra, causing more frequent or urgent urination for a while. For men who already have significant urinary symptoms before treatment, the guideline conditionally favors the roughly one-month course over five-session SBRT, because SBRT may make urinary side effects worse in these men.

If you already get up several times a night to urinate or have a weak stream, mention it before your radiation plan is set. It is one of the details that helps your team choose between the two shorter options.

4. Prostate Cancer Radiation Planning Details Still Matter

Shorter treatment is paired with careful technique. The guideline recommends using MRI to help map the prostate, tracking the prostate's position daily because it can shift with bladder and bowel filling, and using intensity-modulated radiation therapy (IMRT), which shapes the beams to spare nearby organs.

It also says doctors should talk with patients about rectal spacers, a gel placed between the prostate and rectum to protect the bowel, through shared decision-making. Decisions about adding hormone therapy (androgen deprivation therapy) are made separately and should not change based on which radiation schedule you choose. Treating the pelvic lymph nodes with five-session SBRT is recommended only in clinical trials.

5. Shorter Prostate Cancer Radiation Means Fewer Trips and Less Time Off

Fewer trips to the radiation center means less time off work, less driving and parking, and fewer days a caregiver needs to rearrange. ASTRO noted that use of shorter courses has varied by race, age and income, and the guideline is meant to make these options more widely offered.

These recommendations cover radiation as the main treatment for prostate cancer that has not spread. They do not address radiation given after prostate surgery. CURE has covered research on that situation in a story on shorter radiation after prostate surgery.

If radiation is part of your plan, it is reasonable to ask your radiation oncologist which schedule they recommend for you and why, and whether a shorter course is offered at your treatment center. For a patient's long view of life after diagnosis, read one man's reflections 10 years after his prostate cancer diagnosis.

References

  1. "Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO Clinical Practice Guideline." Practical Radiation Oncology. 2026.

For more news on cancer updates, research and education, don't forget to subscribe to CURE®'s newsletters here.


Related to this article